Evidence map›Paper›PMID 33980671›Full record

ArticlemSphere2021

Leptin Deficiency, Caused by Malnutrition, Makes You Susceptible to SARS-CoV-2 Infection but Could Offer Protection from Severe COVID-19.

Dewald Schoeman, Burtram C Fielding

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Leptin as a potential prognostic marker of the severity of COVID-19 infection in obese patients.Nutrition, metabolism, and cardiovascular diseases : NMCD · 2022
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Dewald SchoemanMolecular Biology and Virology Research Laboratory, Department of Medical Biosciences, University of the Western Cape, Bellville, Cape Town, Western Cape, South Africa.
Burtram C FieldingMolecular Biology and Virology Research Laboratory, Department of Medical Biosciences, University of the Western Cape, Bellville, Cape Town, Western Cape, South Africa bfielding@uwc.ac.za.ORCID 0000-0002-1873-3363
University of the Western Cape · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In much of the developing world, severe malnutrition is the most prevalent cause of immunodeficiency and affects up to 50% of the population in some impoverished communities. As yet, we do not know how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) will behave in populations with immunodeficiency caused by malnourishment. Interestingly, researchers are now speculating that, in some instances, a defective cellular immune system could paradoxically be a protective factor against severe disease in certain patients contracting SARS-CoV and SARS-CoV-2. This could be linked to the absence of T-cell activation. Based on available information presented here, it is plausible that the hyperimmune response, and subsequent cytokine storm often associated with severe coronavirus disease 2019 (COVID-19), could be "counteracted" by the defective immune response seen in individuals with malnutrition-induced leptin deficiency. In this paper, we proposed a theory that although those with malnutrition-linked leptin deficiency are at risk of SARS-CoV-2 infection, they are at lower risk of developing severe COVID-19.

Indexed as

SARS-CoV-2Antibody FormationBody Mass IndexCOVID-19COVID-19 VaccinesCytokine Release SyndromeDeveloping CountriesDisease SusceptibilityHumansImmunity, CellularImmunogenicity, VaccineImmunologic Deficiency SyndromesLeptinLymphocyte ActivationMalnutritionModels, BiologicalCOVID-19 VaccinesLEP protein, humanLeptinCOVID-19cytokine stormleptin deficiencymalnutritionSARS-CoV-2undernutrition

Identifiers

PMID33980671
PMCPMC8125045
OpenAlexW3162845870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.